Skip to main content

9 February 2026

Last updated: Sunday 8 February 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Genmab looks ahead to next phase of growth

Sunday 11 November 2018

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Why industry is investing in bispecific molecules

Wednesday 15 June 2016

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Organisations

Abingworth LLP
Cell Medica
Complix NV
Society for Family Health Nigeria
Orchard Therapeutics
Lytix Biopharma AS
Cytograft Tissue Engineering Inc
Harvard Stem Cell Institute
Achilles Therapeutics Ltd
Evotec AG

Interviewees and Contributers

Fredrik Y Frejd
Alexa Machikas and Elena Kfoury
Antonin de Fougerolles
Carl-Johan Dalsgaard
Khalid Ishaque
Jackie Iversen
Patrik De Haes
Michael Valenzuela
Steven Powell
Nick Ray

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

German biotech DISCO Pharmaceuticals appoints CEO

Monday 19 January 2026

argenx in CEO transition

Monday 19 January 2026

PureTech Health appoints CEO

Monday 19 January 2026

New CEO at Tacalyx

Monday 19 January 2026

Tubulis appoints oncology expert as CMO

Monday 19 January 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form